Sveriges mest populära poddar
Prostate Cancer Update
Hälsa och motionMedicin

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit

49 min•17 juni 2026

Featuring perspectives from Dr Terence Friedlander and Dr Daniel P Petrylak, including the following topics:

  • Introduction (0:00)
  • Role of Immunotherapeutic Strategies in the Management of Nonmetastatic Urothelial Bladder Cancer (UBC); Emerging Utility of Circulating Tumor DNA Evaluation — Dr Friedlander (3:53)
  • Other Novel Agents and Strategies for Nonmetastatic and Metastatic UBC — Dr Petrylak (26:41)

CME information and select publications

Fler avsnitt av Prostate Cancer Update

Visa alla avsnitt av Prostate Cancer Update
AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
•19 min
AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
•17 min
Genitourinary Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
•1 tim 30 min
Metastatic Bladder Cancer — Rapid Case Review Issue 6
•26 min
Metastatic Bladder Cancer — Rapid Case Review Issue 5
•29 min
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
•20 min
Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
•23 min
Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
•1 tim 59 min
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
•36 min
For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
•1 tim 30 min

Prostate Cancer Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.